Search

everythinglearnresearchcommunity

for

Search:↓

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

At least 87% of Indian men experience hair loss, with type II being most common and severity increasing with age.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

Finasteride cream reduces hair growth in women with hirsutism, but more research needed.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Metformin helped improve the quality of life for Chinese women with PCOS, especially in physical health and symptoms like infertility, acne, and hair loss.

The conclusion is that skin and hair patterns are formed by a mix of cell activities, molecular signals, and environmental factors.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in patients with Tourette syndrome.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.